Structure of Class B GPCRs: new horizons for drug discovery.
about
Landmark studies on the glucagon subfamily of GPCRs: from small molecule modulators to a crystal structureNovel Structural Approaches to Study GPCR RegulationNovel Allosteric Modulators of G Protein-coupled ReceptorsTransmembrane signal transduction by peptide hormones via family B G protein-coupled receptorsGeneric GPCR residue numbers - aligning topology maps while minding the gapsStructural insights into ligand recognition and selectivity for classes A, B, and C GPCRsActions of the small molecule ligands SW106 and AH-3960 on the type-1 parathyroid hormone receptor.International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors--family B G protein-coupled receptors.Towards a structural understanding of allosteric drugs at the human calcium-sensing receptorDifferential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled ReceptorsIdentification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism.Structural insight into the activation of a class B G-protein-coupled receptor by peptide hormones in live human cells.Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties.Decoding Corticotropin-Releasing Factor Receptor Type 1 Crystal Structures.Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding.Development of Potent, Protease-Resistant Agonists of the Parathyroid Hormone Receptor with Broad β Residue Distribution.GPCR Retreat 2014: a good view leads to many discoveries!Molecular Modeling of Structures and Interaction of Human Corticotropin-Releasing Factor (CRF) Binding Protein and CRF Type-2 Receptor.
P2860
Q26798049-91D9CF1F-5E18-4614-9E55-EA278FBA1617Q28067568-CDDDF56F-3469-4D4B-B250-7E4BBFF37F73Q28081112-FA7D3775-0FCB-49CA-B5B3-D7F5E48337C5Q28082755-A81AEE01-42C6-4012-AA53-97124715E22CQ28087587-13E201E9-E8E3-4241-822A-CD591D594E1AQ28088311-6EDFC226-0D66-4881-9592-E476D826C2D0Q35054974-93BF1D0F-71EC-43ED-BE60-34148E3AC4DEQ35383816-CD6027AE-DAA8-4E4D-A5D2-C3F010C19753Q36869965-2A3C7672-E951-4E36-9633-0A4B384E3B5AQ37098923-06A09B54-56CF-490C-9133-BF31EEF56413Q37430684-C98A14D6-CC10-4C3E-9763-D7E826C127DBQ38644545-AA9844A6-EFCB-4702-8B79-F53E5DDE94C7Q42571235-E46895A1-57CC-47B5-9F52-51156ED5D849Q45142290-1BA78D9F-091D-4EC7-A6EC-D5843D0647AFQ47130308-1F135DC0-A0AF-4F96-902A-1C284F3CAF3DQ47416630-497978E5-AC04-456B-A2CD-882F226B6BF4Q51288462-A9CFE072-79B7-44EC-9E05-934D45190E44Q53439320-AA35A25F-9F3A-4220-924D-79A8794B701B
P2860
Structure of Class B GPCRs: new horizons for drug discovery.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Structure of Class B GPCRs: new horizons for drug discovery.
@en
type
label
Structure of Class B GPCRs: new horizons for drug discovery.
@en
prefLabel
Structure of Class B GPCRs: new horizons for drug discovery.
@en
P2093
P2860
P356
P1476
Structure of Class B GPCRs: new horizons for drug discovery.
@en
P2093
Andrea Bortolato
Andrew S Doré
Benjamin G Tehan
Jonathan S Mason
Kaspar Hollenstein
P2860
P304
P356
10.1111/BPH.12689
P407
P577
2014-07-01T00:00:00Z